You are here

  • Home
  • Archive
  • Volume 78, Issue Suppl 2
  • OP0224 RESULTS OF A PHASE 2 STUDY OF RG6125, AN ANTI-CADHERIN-11 MONOCLONAL ANTIBODY, IN RHEUMATOID ARTHRITIS PATIENTS WITH AN INADEQUATE RESPONSE TO ANTI-TNFALPHA THERAPY

Article metrics

Article menu

Download PDFPDF

Oral Presentations
FRIDAY, 14 JUNE 2019
Osteoarthritis: Research in motion
Rheumatoid arthritis – biological DMARDs
OP0224 RESULTS OF A PHASE 2 STUDY OF RG6125, AN ANTI-CADHERIN-11 MONOCLONAL ANTIBODY, IN RHEUMATOID ARTHRITIS PATIENTS WITH AN INADEQUATE RESPONSE TO ANTI-TNFALPHA THERAPY
Free

 

Online download statistics by month:

Online download statistics by month: May 2019 to November 2024

AbstractFullPdf
May 2019201
Jun 201960041
Jul 201995017
Aug 201952010
Sep 20196909
Oct 201970012
Nov 201982011
Dec 201995015
Jan 20205504
Feb 20204307
Mar 20206605
Apr 2020116016
May 20206607
Jun 202071015
Jul 20207008
Aug 20204204
Sep 20209607
Oct 202054010
Nov 202052012
Dec 202058011
Jan 20215805
Feb 20216908
Mar 20215407
Apr 202172010
May 202165016
Jun 2021105
Jul 20214011
Aug 2021207
Sep 20210014
Oct 202151025
Nov 202138021
Dec 20215306
Jan 20227703
Feb 202249014
Mar 202245010
Apr 20223404
May 202289019
Jun 202274021
Jul 2022134016
Aug 20228008
Sep 202280021
Oct 2022136012
Nov 202299014
Dec 20226805
Jan 2023121012
Feb 20237009
Mar 202380010
Apr 202376014
May 202386011
Jun 2023224018
Jul 202311309
Aug 2023122012
Sep 202380010
Oct 2023121012
Nov 2023165030
Dec 20239207
Jan 20246808
Feb 20246306
Mar 202480022
Apr 2024168024
May 2024112018
Jun 202492016
Jul 2024123010
Aug 202478011
Sep 2024281012
Oct 20249809
Nov 2024130015
Total53890809